Thomas Guiel
Patrimonio netto: 9 306 $ in data 31/07/2026
Patrimonio netto: 9 306 $ in data 31/07/2026
Thomas G.
Guiel worked as Principal at Invitrogen Corp., Vice President-Operations at CapForce, Inc., Chief Operating Officer & Executive Vice President at OncoPlex Diagnostics, Inc. from 2013 to 2018, and Chief Operating Officer at Oxford BioDynamics Plc.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 10/11/2025 | 6.288.146 ( 0,15% ) | 9 306 $ | 31/07/2026 |
| Società | Posizione | Fine |
|---|---|---|
OncoPlex Diagnostics, Inc.
OncoPlex Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates a cancer diagnostics laboratory | Direttore operativo | 01/01/2018 |
| OXFORD BIODYNAMICS PLC | Direttore operativo | - |
| CAPFORCE INC. | Direttore operativo | - |
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and sells life science research kits and provides research services | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
| Aziende private | 4 |
|---|---|
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and sells life science research kits and provides research services | Electronic Technology |
OpGen, Inc.
OpGen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technologies against life-threatening, antibiotic-resistant infections using molecular diagnostics and bioinformatics | Commercial Services |
OncoPlex Diagnostics, Inc.
OncoPlex Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates a cancer diagnostics laboratory | Health Services |
Oxford BioDynamics Plc
Oxford BioDynamics Plc BiotechnologyHealth Technology Discovers and develops novel biomarkers | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale